China A-share innovative drug sector opened weaker; Ha Sanlian hit the daily
down-limit, while Zhongguancun, Zhongsheng Pharma, Yibai Pharmaceutical, Shiyao
Innovation, Sanyuan Gene and Laimei Pharmaceutical also fell.
2026-08-25
China A-share innovative drug sector opened weaker; Ha Sanlian hit the daily
down-limit, while Zhongguancun, Zhongsheng Pharma, Yibai Pharmaceutical, Shiyao
Innovation, Sanyuan Gene and Laimei Pharmaceutical also fell.